{"name": "Chroma Therapeutics",
 "permalink": "chroma-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/chroma-therapeutics",
 "homepage_url": "http://www.chromatherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "Chroma Therapeutics Ltd.",
 "email_address": "pa@chromatherapeutics.com",
 "phone_number": "44-(0)1235-829120",
 "description": "cancer and inflammation treatments",
 "created_at": "Tue Jul 07 20:28:36 UTC 2009",
 "updated_at": "Wed May 01 02:35:32 UTC 2013",
 "overview": "\u003Cp\u003EChroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. Chroma is the first company to systematically assemble intellectual property in chromatin biology and has established a strong network of academic collaborators. Chroma aims to build substantial shareholder value through the creation of a broad and innovative product pipeline aimed at the treatment of high-prevalence cancers and inflammatory disorders.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       52],
      "assets/images/resized/0005/2160/52160v1-max-150x150.jpg"],
     [[250,
       87],
      "assets/images/resized/0005/2160/52160v1-max-250x250.jpg"],
     [[257,
       90],
      "assets/images/resized/0005/2160/52160v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$77.5M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "",
    "source_description": "Capital Report Index",
    "raised_amount": 24500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 6,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Abingworth",
         "permalink": "abingworth-management",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0003/6134/36134v2-max-150x150.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-250x250.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Essex Woodlands Health Ventures",
         "permalink": "essex-woodlands-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0005/2525/52525v3-max-150x150.jpg"],
             [[250,
               139],
              "assets/images/resized/0005/2525/52525v3-max-250x250.jpg"],
             [[268,
               150],
              "assets/images/resized/0005/2525/52525v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Gilde IT Fund",
         "permalink": "gilde-it-fund",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0003/1535/31535v1-max-150x150.png"],
             [[200,
               56],
              "assets/images/resized/0003/1535/31535v1-max-250x250.png"],
             [[200,
               56],
              "assets/images/resized/0003/1535/31535v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Wellcome Trust",
         "permalink": "wellcome-trust",
         "image":
          {"available_sizes":
            [[[150,
               12],
              "assets/images/resized/0002/9701/29701v2-max-150x150.jpg"],
             [[250,
               20],
              "assets/images/resized/0002/9701/29701v2-max-250x250.jpg"],
             [[450,
               37],
              "assets/images/resized/0002/9701/29701v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "GlaxoSmithKline",
         "permalink": "glaxosmithkline",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0005/1020/51020v1-max-150x150.png"],
             [[158,
               54],
              "assets/images/resized/0005/1020/51020v1-max-250x250.png"],
             [[158,
               54],
              "assets/images/resized/0005/1020/51020v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Nomura Securities",
         "permalink": "nomura-securities",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0002/9415/29415v1-max-150x150.png"],
             [[171,
               30],
              "assets/images/resized/0002/9415/29415v1-max-250x250.png"],
             [[171,
               30],
              "assets/images/resized/0002/9415/29415v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.chromatherapeutics.com/press-releases/Press-Release-7.pdf",
    "source_description": "CHROMA THERAPEUTICS COMPLETES $53 MILLION SERIES C FINANCING",
    "raised_amount": 53000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 4,
    "funded_day": 3,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Nomura Phase4 Ventures",
         "permalink": "nomura-phase4-ventures",
         "image":
          {"available_sizes":
            [[[130,
               21],
              "assets/images/resized/0005/2875/52875v1-max-150x150.png"],
             [[130,
               21],
              "assets/images/resized/0005/2875/52875v1-max-250x250.png"],
             [[130,
               21],
              "assets/images/resized/0005/2875/52875v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Abingworth",
         "permalink": "abingworth-management",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0003/6134/36134v2-max-150x150.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-250x250.jpg"],
             [[221,
               73],
              "assets/images/resized/0003/6134/36134v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Essex Woodlands Health Ventures",
         "permalink": "essex-woodlands-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0005/2525/52525v3-max-150x150.jpg"],
             [[250,
               139],
              "assets/images/resized/0005/2525/52525v3-max-250x250.jpg"],
             [[268,
               150],
              "assets/images/resized/0005/2525/52525v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Gilde Healthcare Partners",
         "permalink": "gilde-healthcare-partners",
         "image":
          {"available_sizes":
            [[[150,
               44],
              "assets/images/resized/0005/3138/53138v2-max-150x150.png"],
             [[201,
               59],
              "assets/images/resized/0005/3138/53138v2-max-250x250.png"],
             [[201,
               59],
              "assets/images/resized/0005/3138/53138v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "The Welcom Trust",
         "permalink": "the-welcom-trust",
         "image":
          {"available_sizes":
            [[[150,
               23],
              "assets/images/resized/0006/3746/63746v1-max-150x150.png"],
             [[171,
               27],
              "assets/images/resized/0006/3746/63746v1-max-250x250.png"],
             [[171,
               27],
              "assets/images/resized/0006/3746/63746v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "93 Milton Park ",
    "address2": "Abingdon ",
    "zip_code": "OX14 4RY ",
    "city": "Oxon ",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        120],
       "assets/images/resized/0006/3756/63756v1-max-150x150.jpg"],
      [[250,
        200],
       "assets/images/resized/0006/3756/63756v1-max-250x250.jpg"],
      [[450,
        360],
       "assets/images/resized/0006/3756/63756v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}